It just needs the right trigger
Since the introduction of the Villefranche nosology, research in EDS has expanded, and new subtypes were discovered
According to the WHO report in March 2024, one out of three people globally is concerned with neurological concerns, that is, 3 billion people, which is a rise of 18% over the past few decades
However, these side effects are often intermittent, mild, and short-lived, Fishman says
In an interview with People magazine, she said, "In my entire life, I never dreamed that we would be talking about medicines that are providing hope for people like me who have struggled for years with being overweight or with obesity." She also shed light on the chronic nature of the drug, noting that after she tried to stop taking it, she regained weight, realising, "Its going to be a lifetime thing"